Cytel News

Cytel

Labiotech UG • October 14, 2022

U.S.-based Cytel Inc. has entered into an agreement to acquire Scandinavian companies SDS Life Sciences AB and SDS MedeQ AB.

Labiotech UG

Cytel signs agreement with two Scandinavian companies

https://www.labiotech.eu/trends-news/cytel-signs-agreement-with-two-scandinavian-companies/

Cytel

Scientific Computing World • October 13, 2022

Cytel has announced an agreement to acquire SDS Life Science AB and SDS MedteQ AB - bolstering expertise in strategic therapeutic development

Scientific Computing World

Cytel to acquire SDS Life Science and SDS MedteQ

https://www.scientific-computing.com/press-releases/cytel-acquire-sds-life-science-and-sds-medteq

Cytel

MM+M - Medical Marketing and Media • October 3, 2022

Kranzler, who has been an advisor to Urica, is expanding his role with the biopharma and will manage the development of its gout candidate.

MM+M - Medical Marketing and Media

Urica Therapeutics taps Pfizer's Jay D. Kranzler for CEO post

https://www.mmm-online.com/home/channel/people-moves/urica-therapeutics-taps-pfizers-jay-d-kranzler-for-ceo-post/

Cytel

open access to scientific and medical research • August 1, 2022

JET-RANGER study ;a multicenter randomized trial, core lab adjudicated, designed to demonstrate the superiority of JET+PCB versus PTA+PCB to treat FP arterial

open access to scientific and medical research

JET-RANGER Study | VHRM

https://www.dovepress.com/jetstream-atherectomy-followed-by-paclitaxel-coated-balloons-versus-ba-peer-reviewed-fulltext-article-VHRM

Cytel

Travel Adventure Cinema Tourist News • July 21, 2022

Primary and secondary root canal treatments of maxillary premolars and molars reduce the inflammation of the maxillary sinus 3 months after treatment according to a recent study published in the...

Travel Adventure Cinema Tourist News

Primary and secondary RCT of maxillary premolars and molars reduces maxillary sinus inflammation

https://medicaldialogues.in/dentistry/news/primary-and-secondary-rct-of-maxillary-premolars-and-molars-reduces-maxillary-sinus-inflammation-96356

Cytel

Travel Adventure Cinema Tourist News • July 21, 2022

Clinical Data Management Market to Witness Robust Expansion by 2029 | Ofni Systems, Quanticate, Oracle – Travel Adventure Cinema  Travel Adventure Cinema

Travel Adventure Cinema Tourist News

Clinical Data Management Market to Witness Robust Expansion by 2029 | Ofni Systems, Quanticate, Oracle – Travel Adventure Cinema

https://traveladventurecinema.com/news/377540/clinical-data-management-market-to-witness-robust-expansion-by-2029-ofni-systems-quanticate-oracle/

Cytel

Forbes • July 18, 2022

Huge Demand of Clinical Data Management Market by 2029 | Medidata, Oracle, CliniOps – Travel Adventure Cinema  Travel Adventure Cinema

Forbes

Huge Demand of Clinical Data Management Market by 2029 | Medidata, Oracle, CliniOps – Travel Adventure Cinema

https://traveladventurecinema.com/news/212185/huge-demand-of-clinical-data-management-market-by-2029-medidata-oracle-cliniops/

Cytel

Forbes • July 18, 2022

Hong Kong-trade shares have lost nearly 36% in past year

Forbes

“Wealth” Products Hurt Globally Acquisitive Pharmaron Beijing’s 1st Half Profit

https://www.forbes.com/sites/russellflannery/2022/07/17/wealth-products-hurt-globally-acquisitive-pharmaron-beijings-1st-half-profit/

Cytel

Seeking Alpha • June 28, 2022

The global CRO services market is projected to surpass $70 billion in 2022.

Seeking Alpha

Lindsay Goldberg backs data-powered contract research organization MMS

https://www.axios.com/pro/health-tech-deals/2022/06/28/lindsay-goldberg-mms-cro-contract-research-organization-pharma-services-emmes-cytel

Cytel

Seeking Alpha • June 28, 2022

Concentrix Corporation (NASDAQ:NASDAQ:CNXC) Q2 2022 Earnings Conference Call June 28, 2022, 9:00 AM ET Company Participants David Stein - Vice President, Investor Relations Chris Caldwell -...

Seeking Alpha

Concentrix Corporation's (CNXC) CEO Chris Caldwell on Q2 2022 Results

https://seekingalpha.com/article/4520782-concentrix-corporations-cnxc-ceo-chris-caldwell-on-q2-2022-results-earnings-call-transcript

Cytel

StreetInsider.com • June 24, 2022

John C. Byrd, M.D., Renowned Cancer Clinician and Researcher, Named Chair of Scientific Advisory Board New Collaboration with Northeast Ohio Medical University Further Demonstrates...

StreetInsider.com

Orange Grove Bio Provides Corporate Update Highlighting Key Leadership Appointments and Establishment of New Academic Collaboration

https://www.streetinsider.com/Globe+Newswire/Orange+Grove+Bio+Provides+Corporate+Update+Highlighting+Key+Leadership+Appointments+and+Establishment+of+New+Academic+Collaboration/20245634.html

Cytel

Axios • June 21, 2022

The Netherlands company is one of few platform-ready outsourced service providers dedicated to medical devices.

Axios

Scoop: Astorg buys medical device CRO Avania

https://www.axios.com/pro/health-tech-deals/2022/06/21/astorg-avania-cro-medical-device-medtech

Cytel

open access to scientific and medical research • June 17, 2022

This systematic literature review analyzed published evidence on epidemiology and burden of illness of asthma and COPD.

open access to scientific and medical research

Mortality of asthma and COPD in COVID-19 | JAA

https://www.dovepress.com/epidemiology-healthcare-resource-utilization-and-mortality-of-asthma-a-peer-reviewed-fulltext-article-JAA

Cytel

PR Newswire • June 14, 2022

/PRNewswire/ -- Riverside Partners, a Boston based private equity firm, announced today that its portfolio company, Syner-G BioPharma Group (“Syner-G” or the...

PR Newswire

Riverside Partners' Portfolio Company, Syner-G BioPharma Group, Appoints Ron Kraus as CEO

https://www.prnewswire.com/news-releases/riverside-partners-portfolio-company-syner-g-biopharma-group-appoints-ron-kraus-as-ceo-301567919.html

Cytel

PharmExec • June 13, 2022

Kraus brings more than 25 years of experience leading life sciences companies, including global responsibility for customer strategy, sales, operations, and various support functions.

PharmExec

Syner-G Biopharma Group Appoints Ron Kraus as CEO

https://www.pharmexec.com/view/syner-g-biopharma-group-appoints-ron-kraus-as-ceo

Cytel

Pink Sheet • May 26, 2022

<p>US FDA workshop on efforts to advance pharmacokinetic data collection in pregnant women highlights the (slow-moving) antiretroviral experience, but COVID therapies show that regulatory receptiveness is a poor match for recruitment and liability concerns.</p>

Pink Sheet

PK Evaluation In Pregnancy: Can HIV Show A Way Forward?

https://pink.pharmaintelligence.informa.com/PS146231/PK-Evaluation-In-Pregnancy-Can-HIV-Show-A-Way-Forward

Cytel

Benzinga • May 24, 2022

Dublin, May 24, 2022 (GLOBE NEWSWIRE) -- The “Global Clinical Trial Management System (CTMS) Market - Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering. The global

Benzinga

Global Clinical Trial Management System (CTMS) Market Report 2022: A $2.75+ Billion Market by 2027

https://www.benzinga.com/pressreleases/22/05/g27363387/global-clinical-trial-management-system-ctms-market-report-2022-a-2-75-billion-market-by-2027-incr

Cytel

WFMZ.com • May 23, 2022

DUBLIN, May 23, 2022 /PRNewswire/ -- The “Global Clinical Trial Management System (CTMS) Market - Forecasts from 2022 to 2027” report has been added to ResearchAndMarkets.com’s offering.

WFMZ.com

Global Clinical Trial Management System (CTMS) Market Report 2022-2027: Breakdown by Pharmaceutical and Biotechnology Companies, Contract Research Organizations, & Medical Device Manufacturers

https://www.wfmz.com/news/pr_newswire/pr_newswire_health/global-clinical-trial-management-system-ctms-market-report-2022-2027-breakdown-by-pharmaceutical-and-biotechnology/article_d42cc3fd-5d30-5899-a369-abdf26ed6e27.html

Cytel

The Daily News • May 18, 2022

DUBLIN--(BUSINESS WIRE)--May 18, 2022--

The Daily News

Global Clinical Trial Management System (CTMS) Market Research Report 2022

https://www.galvnews.com/news_ap/business/article_833c48b3-8c71-5c79-b9bd-99e65c1b069e.html